Natco Pharma, 524816, NATCOPHARM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

15,280.76
9.00
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

13,377.86
0.70%
1.89

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

14.52
16.64
17.84

EBITDA CAGR (%)

10 Years
5 Years
3 Years

23.19
29.44
19.20

PAT CAGR (%)

10 Years
5 Years
3 Years

28.21
33.73
38.14

P:E (Median)

8 Years
5 Years
3 Years

21.55
25.31
15.31

P:BV (Average)

8 Years
5 Years
3 Years

3.57
3.20
2.81

EV:EBITDA (Average)

8 Years
5 Years
3 Years

16.61
17.62
11.07

Earnings Forecasts:

(Updated: 04-09-2025)

Description 2024 2025 2026 2027
Adj EPS 105.33 80.02 35.84 45.88
P/E Ratio 8.10 10.66 23.79 18.59
Revenue 4429.5 4319.99 3157.06 3764.53
EBITDA 2196 1721.66 712.22 765.9
Net Income 1885.4 1437 643.61 821.57
ROA 24.27 20.19 6.79 5.63
P/B Ratio 2.01 1.76 1.64 1.62
ROE 28.01 18.17 7.14 8.27
FCFF 1428 1348.27 753.03 1848.26
FCFF Yield 8.88 8.38 4.68 11.49
Net Debt -2217.4
BVPS 424.97 483.63 520.69 525.91

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 1,192.70 1,236.90 -3.57% 1,157.40 964.80 19.96% 407.60 625.30 -34.82% 1,292.60 930.50 38.91%
Expenses 653.00 473.90 37.79% 596.20 512.10 16.42% 378.20 387.00 -2.27% 501.90 488.20 2.81%
EBITDA 539.70 763.00 -29.27% 561.20 452.70 23.97% 29.40 238.30 -87.66% 790.70 442.30 78.77%
EBIDTM 45.25% 61.69% 48.49% 46.92% 7.21% 38.11% 61.17% 47.53%
Other Income 59.60 39.80 49.75% 62.10 35.90 72.98% 168.00 29.50 469.49% 51.40 24.70 108.10%
Interest 2.60 4.40 -40.91% 8.80 4.50 95.56% 3.40 3.80 -10.53% 3.00 3.00 0.00%
Depreciation 53.80 40.40 33.17% 93.70 51.60 81.59% 43.70 40.40 8.17% 42.20 40.00 5.50%
PBT 542.90 758.00 -28.38% 520.80 432.50 20.42% 150.30 223.60 -32.78% 796.90 424.00 87.95%
Tax 78.80 121.70 -35.25% 92.70 83.40 11.15% 25.40 31.60 -19.62% 135.80 63.80 112.85%
PAT 464.10 636.30 -27.06% 428.10 349.10 22.63% 124.90 192.00 -34.95% 661.10 360.20 83.54%
PATM 38.91% 51.44% 36.99% 36.18% 30.64% 30.71% 51.15% 38.71%
EPS 25.91 35.53 -27.08% 23.90 19.49 22.63% 6.97 10.72 -34.98% 36.91 20.11 83.54%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 1,328.90 1,362.60 -2.47% 1,221.00 1,068.30 14.29% 474.80 758.60 -37.41% 1,371.10 1,031.40 32.94%
Expenses 757.90 557.80 35.87% 672.90 571.00 17.85% 436.00 490.50 -11.11% 566.80 573.40 -1.15%
EBITDA 571.00 804.80 -29.05% 548.10 497.30 10.22% 38.80 268.10 -85.53% 804.30 458.00 75.61%
EBIDTM 42.97% 59.06% 44.89% 46.55% 8.17% 35.34% 58.66% 44.41%
Other Income 61.70 48.10 28.27% 66.30 42.00 57.86% 176.30 37.00 376.49% 63.80 29.40 117.01%
Interest 3.20 5.20 -38.46% 10.20 6.20 64.52% 4.40 4.60 -4.35% 4.10 4.20 -2.38%
Depreciation 57.60 44.10 30.61% 98.30 55.50 77.12% 47.00 44.20 6.33% 45.80 43.60 5.05%
PBT 571.90 803.60 -28.83% 505.90 477.60 5.93% 163.70 256.30 -36.13% 818.20 439.60 86.12%
Tax 91.60 135.10 -32.20% 99.90 91.30 9.42% 31.30 43.60 -28.21% 141.70 70.60 100.71%
PAT 480.30 668.50 -28.15% 406.00 386.30 5.10% 132.40 212.70 -37.75% 676.50 369.00 83.33%
PATM 36.14% 49.06% 33.25% 36.16% 27.89% 28.04% 49.34% 35.78%
EPS 26.85 37.35 -28.11% 22.72 21.58 5.28% 7.43 11.88 -37.46% 37.84 20.61 83.60%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 4,050.30 4,094.50 3,568.90 2,351.00 1,767.80 1,653.50 1,790.20 1,986.30 2,091.30 1,958.00 1,021.40 Net Sales Growth 7.79% 14.73% 51.80% 32.99% 6.91% -7.64% -9.87% -5.02% 6.81% 91.70% Cost Of Goods Sold 631.40 545.00 525.80 485.60 502.10 472.30 369.80 317.60 388.50 572.80 256.30 Gross Profit 3,418.90 3,549.50 3,043.10 1,865.40 1,265.70 1,181.20 1,420.40 1,668.70 1,702.80 1,385.20 765.10 GP Margin 84.41% 86.69% 85.27% 79.34% 71.60% 71.44% 79.34% 84.01% 81.42% 70.75% 74.91% Total Expenditure 2,129.30 1,952.40 1,931.90 1,530.20 1,554.80 1,238.30 1,212.20 1,169.80 1,162.90 1,266.00 740.70 Power & Fuel Cost - 93.10 88.90 81.90 76.40 59.40 62.40 59.60 56.10 50.50 43.70 % Of Sales - 2.27% 2.49% 3.48% 4.32% 3.59% 3.49% 3.00% 2.68% 2.58% 4.28% Employee Cost - 515.30 454.90 425.70 410.10 380.00 356.10 340.20 312.20 232.10 171.90 % Of Sales - 12.59% 12.75% 18.11% 23.20% 22.98% 19.89% 17.13% 14.93% 11.85% 16.83% Manufacturing Exp. - 357.70 341.70 269.90 340.80 160.50 230.40 257.50 175.10 134.20 100.60 % Of Sales - 8.74% 9.57% 11.48% 19.28% 9.71% 12.87% 12.96% 8.37% 6.85% 9.85% General & Admin Exp. - 246.80 253.10 155.70 122.50 92.60 111.20 103.90 96.00 78.30 56.90 % Of Sales - 6.03% 7.09% 6.62% 6.93% 5.60% 6.21% 5.23% 4.59% 4.00% 5.57% Selling & Distn. Exp. - 105.60 117.40 59.50 27.00 29.20 22.60 33.50 98.00 128.80 88.40 % Of Sales - 2.58% 3.29% 2.53% 1.53% 1.77% 1.26% 1.69% 4.69% 6.58% 8.65% Miscellaneous Exp. - 88.90 150.10 51.90 75.90 44.30 59.70 57.50 37.00 69.30 88.40 % Of Sales - 2.17% 4.21% 2.21% 4.29% 2.68% 3.33% 2.89% 1.77% 3.54% 2.24% EBITDA 1,921.00 2,142.10 1,637.00 820.80 213.00 415.20 578.00 816.50 928.40 692.00 280.70 EBITDA Margin 47.43% 52.32% 45.87% 34.91% 12.05% 25.11% 32.29% 41.11% 44.39% 35.34% 27.48% Other Income 341.10 323.50 104.70 109.40 94.60 103.50 123.80 129.80 39.40 13.20 12.90 Interest 17.80 19.60 14.50 8.60 13.30 11.30 20.60 18.80 14.70 17.50 21.90 Depreciation 233.40 220.00 171.90 150.90 138.40 115.20 98.10 80.10 65.50 53.60 50.20 PBT 2,010.90 2,226.00 1,555.30 770.70 155.90 392.20 583.10 847.40 887.60 634.10 221.50 Tax 332.70 375.60 248.70 133.60 16.80 82.70 108.60 180.30 189.40 139.30 45.00 Tax Rate 16.54% 16.87% 15.99% 17.33% 10.78% 21.09% 18.62% 21.28% 21.34% 21.97% 20.32% PAT 1,678.20 1,850.40 1,306.60 637.10 139.10 309.50 474.50 667.10 698.20 494.80 176.50 PAT before Minority Interest 1,678.20 1,850.40 1,306.60 637.10 139.10 309.50 474.50 667.10 698.20 494.80 176.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 41.43% 45.19% 36.61% 27.10% 7.87% 18.72% 26.51% 33.59% 33.39% 25.27% 17.28% PAT Growth 9.14% 41.62% 105.09% 358.02% -55.06% -34.77% -28.87% -4.45% 41.11% 180.34% EPS 93.70 103.32 72.95 35.57 7.77 17.28 26.49 37.25 38.98 27.63 9.85

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 4,395.80 4,429.50 3,998.80 2,707.10 1,944.80 2,052.10 1,915.00 2,094.50 2,184.80 2,020.20 1,141.30 Net Sales Growth 4.14% 10.77% 47.72% 39.20% -5.23% 7.16% -8.57% -4.13% 8.15% 77.01% Cost Of Goods Sold 742.60 641.50 667.90 583.20 528.40 483.70 354.40 332.70 411.10 599.10 341.10 Gross Profit 3,653.20 3,788.00 3,330.90 2,123.90 1,416.40 1,568.40 1,560.60 1,761.80 1,773.70 1,421.10 800.20 GP Margin 83.11% 85.52% 83.30% 78.46% 72.83% 76.43% 81.49% 84.12% 81.18% 70.34% 70.11% Total Expenditure 2,433.60 2,235.70 2,247.40 1,795.40 1,681.30 1,448.30 1,332.40 1,299.70 1,256.40 1,336.80 868.70 Power & Fuel Cost - 93.10 88.90 81.90 76.40 61.10 62.40 59.60 56.20 50.50 43.70 % Of Sales - 2.10% 2.22% 3.03% 3.93% 2.98% 3.26% 2.85% 2.57% 2.50% 3.83% Employee Cost - 594.50 525.00 486.70 444.80 414.90 375.00 355.90 325.60 243.20 189.60 % Of Sales - 13.42% 13.13% 17.98% 22.87% 20.22% 19.58% 16.99% 14.90% 12.04% 16.61% Manufacturing Exp. - 374.80 368.40 279.60 353.60 165.70 243.30 276.40 182.60 141.20 105.20 % Of Sales - 8.46% 9.21% 10.33% 18.18% 8.07% 12.70% 13.20% 8.36% 6.99% 9.22% General & Admin Exp. - 304.00 313.00 208.80 152.80 242.90 132.60 126.40 105.50 88.10 73.40 % Of Sales - 6.86% 7.83% 7.71% 7.86% 11.84% 6.92% 6.03% 4.83% 4.36% 6.43% Selling & Distn. Exp. - 136.40 153.00 96.10 43.70 34.40 98.10 90.00 136.90 143.20 91.60 % Of Sales - 3.08% 3.83% 3.55% 2.25% 1.68% 5.12% 4.30% 6.27% 7.09% 8.03% Miscellaneous Exp. - 91.40 131.20 59.10 81.60 45.60 66.60 58.70 38.50 71.50 91.60 % Of Sales - 2.06% 3.28% 2.18% 4.20% 2.22% 3.48% 2.80% 1.76% 3.54% 2.11% EBITDA 1,962.20 2,193.80 1,751.40 911.70 263.50 603.80 582.60 794.80 928.40 683.40 272.60 EBITDA Margin 44.64% 49.53% 43.80% 33.68% 13.55% 29.42% 30.42% 37.95% 42.49% 33.83% 23.89% Other Income 368.10 356.70 128.10 128.50 99.00 106.00 107.40 130.20 40.40 13.90 9.90 Interest 21.90 23.90 19.20 14.50 17.70 13.30 21.50 19.30 15.40 18.50 22.90 Depreciation 248.70 235.20 186.80 163.80 142.60 116.90 99.80 81.00 66.20 54.40 51.00 PBT 2,059.70 2,291.40 1,673.50 861.90 202.20 579.60 568.70 824.70 887.20 624.40 208.60 Tax 364.50 408.00 285.20 146.60 32.20 137.20 110.60 182.30 192.00 139.50 52.80 Tax Rate 17.70% 17.81% 17.04% 17.01% 15.92% 23.67% 19.45% 22.11% 21.64% 22.34% 25.31% PAT 1,695.20 1,885.40 1,388.30 715.30 170.00 440.90 460.80 644.40 696.20 486.00 157.10 PAT before Minority Interest 1,697.60 1,883.40 1,388.30 715.30 170.00 442.40 458.10 642.40 695.20 484.90 155.80 Minority Interest 2.40 2.00 0.00 0.00 0.00 -1.50 2.70 2.00 1.00 1.10 1.30 PAT Margin 38.56% 42.56% 34.72% 26.42% 8.74% 21.49% 24.06% 30.77% 31.87% 24.06% 13.77% PAT Growth 3.59% 35.81% 94.09% 320.76% -61.44% -4.32% -28.49% -7.44% 43.25% 209.36% EPS 94.65 105.27 77.52 39.94 9.49 24.62 25.73 35.98 38.87 27.14 8.77

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 7,333.90 5,592.30 4,702.00 4,191.90 4,091.10 3,869.50 3,563.20 3,125.40 1,699.70 1,336.30 Share Capital 35.80 35.80 36.50 36.50 36.50 36.40 36.50 36.90 34.90 34.80 Total Reserves 7,298.10 5,556.50 4,665.50 4,152.00 4,037.00 3,809.50 3,495.80 3,064.30 1,649.40 1,291.80 Non-Current Liabilities 30.40 69.00 116.90 134.90 142.90 117.50 83.10 47.00 37.70 27.90 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.90 0.00 0.00 0.00 0.00 Long Term Provisions 65.60 70.90 85.30 95.70 99.60 90.20 71.00 32.40 21.90 12.50 Current Liabilities 864.60 885.60 569.00 651.20 518.50 659.70 709.80 563.80 609.70 478.50 Trade Payables 225.10 183.30 182.40 141.20 139.50 234.20 201.80 245.40 251.40 270.10 Other Current Liabilities 210.70 204.70 201.40 104.00 111.10 93.40 108.50 131.70 122.80 110.90 Short Term Borrowings 273.10 363.20 159.90 389.00 255.10 313.10 384.50 173.00 220.60 96.00 Short Term Provisions 155.70 134.40 25.30 17.00 12.80 19.00 15.00 13.70 14.90 1.50 Total Liabilities 8,228.90 6,546.90 5,387.90 4,978.00 4,752.50 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70 Net Block 2,516.80 2,286.70 2,233.80 2,174.20 2,005.90 1,574.50 1,214.90 1,015.30 829.00 705.60 Gross Block 3,783.70 3,359.50 3,157.10 2,977.80 2,678.30 2,133.70 1,678.20 1,399.60 1,151.00 975.90 Accumulated Depreciation 1,216.90 1,072.80 923.30 803.60 672.40 559.20 463.30 384.30 322.00 270.30 Non Current Assets 3,540.90 3,136.50 2,893.20 2,810.30 2,584.00 2,406.80 2,088.70 1,682.00 1,312.00 1,051.80 Capital Work in Progress 225.30 133.90 62.80 128.70 223.40 517.80 637.50 480.00 336.20 211.90 Non Current Investment 565.10 577.80 517.60 430.40 294.90 186.10 117.60 101.30 85.90 71.70 Long Term Loans & Adv. 73.00 111.50 78.80 72.40 55.60 124.30 110.40 83.10 60.40 62.00 Other Non Current Assets 160.70 26.60 0.20 4.60 4.20 4.10 8.30 2.30 0.50 0.60 Current Assets 4,688.00 3,410.40 2,494.70 2,167.70 2,168.50 2,239.90 2,267.40 2,054.20 1,035.10 790.90 Current Investments 290.00 163.90 139.90 119.60 42.10 5.00 126.80 48.30 8.90 22.10 Inventories 642.10 596.90 616.00 697.70 769.20 524.40 508.40 425.80 336.90 351.90 Sundry Debtors 1,178.20 1,076.60 793.10 575.60 399.80 536.70 491.60 606.00 468.90 255.80 Cash & Bank 1,856.90 864.90 412.00 100.90 262.80 54.10 262.70 172.10 25.10 40.20 Other Current Assets 720.80 86.10 57.60 78.10 694.60 1,119.70 877.90 802.00 195.30 120.90 Short Term Loans & Adv. 597.40 622.00 476.10 595.80 599.40 1,025.90 769.50 748.80 169.60 95.50 Net Current Assets 3,823.40 2,524.80 1,925.70 1,516.50 1,650.00 1,580.20 1,557.60 1,490.40 425.40 312.40 Total Assets 8,228.90 6,546.90 5,387.90 4,978.00 4,752.50 4,646.70 4,356.10 3,736.20 2,347.10 1,842.70

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 7,607.00 5,853.10 4,873.80 4,263.60 4,121.60 3,773.50 3,489.00 3,072.20 1,649.30 1,295.70 Share Capital 35.80 35.80 36.50 36.50 36.50 36.40 36.50 36.90 34.90 34.80 Total Reserves 7,571.20 5,817.30 4,837.30 4,223.70 4,067.60 3,713.60 3,421.70 3,011.40 1,599.00 1,251.20 Non-Current Liabilities 24.90 61.00 100.50 135.10 142.90 117.80 83.40 47.10 37.70 28.00 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.90 0.00 0.00 0.00 0.00 Long Term Provisions 65.60 70.90 85.30 95.70 99.60 90.20 71.00 32.40 21.90 12.50 Current Liabilities 943.50 972.80 683.10 710.40 525.60 685.30 728.70 592.00 626.50 493.10 Trade Payables 274.90 235.50 263.80 161.80 146.20 255.40 217.00 269.10 262.70 275.60 Other Current Liabilities 238.60 238.90 227.30 126.70 99.50 95.90 109.80 133.40 127.10 114.20 Short Term Borrowings 273.10 363.20 165.00 404.00 265.80 315.00 386.30 173.20 221.60 98.40 Short Term Provisions 156.90 135.20 27.00 17.90 14.10 19.00 15.60 16.30 15.10 4.90 Total Liabilities 8,580.70 6,886.90 5,657.40 5,109.10 4,791.90 4,587.80 4,303.10 3,715.10 2,317.60 1,821.70 Net Block 2,698.00 2,490.80 2,426.90 2,311.80 2,023.20 1,584.40 1,227.20 1,018.60 833.00 710.10 Gross Block 4,015.20 3,603.20 3,375.10 3,126.90 2,702.10 2,148.70 1,694.50 1,407.60 1,158.70 983.30 Accumulated Depreciation 1,267.20 1,112.40 948.20 815.10 678.90 564.30 467.30 389.00 325.70 273.20 Non Current Assets 3,310.70 2,863.40 2,657.10 2,622.40 2,447.10 2,262.20 1,955.90 1,584.40 1,230.30 984.70 Capital Work in Progress 225.40 137.30 64.30 129.50 223.40 518.00 637.60 480.00 336.30 211.80 Non Current Investment 152.80 95.90 87.30 104.40 151.90 83.60 19.90 8.10 0.10 0.10 Long Term Loans & Adv. 73.80 112.70 78.30 72.00 44.30 72.00 62.80 75.40 60.40 62.10 Other Non Current Assets 160.70 26.70 0.30 4.70 4.30 4.20 8.40 2.30 0.50 0.60 Current Assets 5,270.00 4,023.50 3,000.30 2,486.70 2,344.80 2,325.60 2,347.20 2,130.70 1,087.30 837.00 Current Investments 320.80 443.50 305.00 203.70 151.80 28.70 148.70 68.40 32.10 22.10 Inventories 765.80 700.50 742.90 762.00 798.20 558.00 529.00 438.40 348.90 357.30 Sundry Debtors 1,246.60 1,188.90 856.10 620.60 412.90 551.30 506.20 637.50 475.20 261.60 Cash & Bank 2,176.00 952.90 546.30 206.10 283.50 66.00 279.50 183.70 35.80 45.20 Other Current Assets 760.80 99.50 64.40 88.10 698.40 1,121.60 883.80 802.70 195.30 150.80 Short Term Loans & Adv. 625.70 638.20 485.60 606.20 603.70 1,030.00 776.40 749.50 169.50 125.40 Net Current Assets 4,326.50 3,050.70 2,317.20 1,776.30 1,819.20 1,640.30 1,618.50 1,538.70 460.80 343.90 Total Assets 8,580.70 6,886.90 5,657.40 5,109.10 4,791.90 4,587.80 4,303.10 3,715.10 2,317.60 1,821.70

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,662.00 1,196.40 784.40 57.70 183.50 422.50 698.80 476.40 329.80 189.90 PBT 2,226.00 1,555.30 770.70 155.90 392.20 583.10 847.40 887.60 634.10 221.50 Adjustment -20.40 150.90 85.40 118.50 58.40 45.20 12.10 74.40 99.80 81.70 Changes in Working Capital -199.00 -257.80 76.70 -184.20 -190.20 -100.70 14.20 -281.20 -281.70 -68.50 Cash after chg. in Working capital 2,006.60 1,448.40 932.80 90.20 260.40 527.60 873.70 680.80 452.20 234.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -344.60 -252.00 -148.40 -32.50 -76.90 -105.10 -174.90 -204.40 -122.40 -44.80 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,443.90 -960.50 -436.60 -92.50 -3.20 -165.00 -645.20 -1,131.10 -290.60 -249.30 Net Fixed Assets -515.60 -273.50 -113.40 -204.80 -250.20 -335.80 -436.10 -392.40 -299.40 -303.91 Net Investments -113.40 -84.20 -107.50 -213.00 -145.90 53.30 -94.80 -54.80 -1.00 37.47 Others -814.90 -602.80 -215.70 325.30 392.90 117.50 -114.30 -683.90 9.80 17.14 Cash from Financing Activity -212.40 -237.30 -346.80 35.60 -183.10 -261.10 -52.20 652.00 -45.60 151.40 Net Cash Inflow / Outflow 5.70 -1.40 1.00 0.80 -2.80 -3.60 1.40 -2.70 -6.40 92.00 Opening Cash & Equivalents 5.50 6.90 5.90 5.10 7.90 11.50 10.10 12.80 19.20 -170.00 Closing Cash & Equivalent 11.20 5.50 6.90 5.90 5.10 7.90 11.50 10.10 12.80 -76.80

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 1,696.80 1,211.60 849.10 46.50 298.80 417.30 668.80 463.60 345.80 112.20 PBT 2,291.40 1,673.50 861.90 202.20 579.60 568.70 824.70 887.20 624.40 208.60 Adjustment -22.30 133.80 102.00 123.90 62.10 54.00 14.30 75.60 100.20 90.50 Changes in Working Capital -199.70 -309.40 62.70 -231.40 -212.90 -97.60 8.60 -294.60 -253.00 -140.70 Cash after chg. in Working capital 2,069.40 1,497.90 1,026.60 94.70 428.80 525.10 847.60 668.20 471.60 158.40 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -372.60 -286.30 -177.50 -48.20 -130.00 -107.80 -178.80 -204.60 -125.80 -46.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,414.50 -1,032.70 -477.10 -5.30 -103.30 -167.00 -612.20 -1,115.50 -299.40 -175.50 Net Fixed Assets -515.60 -273.50 -113.40 -204.80 -250.20 -335.80 -436.10 -392.40 -299.40 -303.91 Net Investments -113.40 -84.20 -107.50 -213.00 -145.90 53.30 -94.80 -54.80 -1.00 37.47 Others -785.50 -675.00 -256.20 412.50 292.80 115.50 -81.30 -668.30 1.00 90.94 Cash from Financing Activity -210.70 -246.90 -363.00 34.80 -185.70 -250.80 -50.90 650.90 -47.70 154.00 Net Cash Inflow / Outflow 71.60 -68.00 9.00 76.00 9.80 -0.50 5.70 -1.00 -1.30 90.70 Opening Cash & Equivalents 70.40 131.90 111.10 25.80 19.80 28.30 21.70 23.50 24.20 -164.10 Closing Cash & Equivalent 120.00 70.40 131.90 111.10 25.80 19.80 28.30 21.70 23.50 -74.20

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 409.72 312.42 257.64 229.51 223.21 211.31 193.55 168.09 96.52 76.24 ROA 25.05% 21.90% 12.29% 2.86% 6.59% 10.54% 16.49% 22.95% 23.62% 10.90% ROE 28.63% 25.38% 14.33% 3.37% 7.82% 12.86% 20.11% 29.18% 32.87% 16.00% ROCE 33.11% 29.02% 16.51% 3.79% 9.46% 14.85% 23.91% 34.58% 38.71% 18.48% Fixed Asset Turnover 1.19 1.15 0.78 0.65 0.70 0.99 1.41 1.65 1.88 1.20 Receivable days 97.17 90.80 104.18 96.61 101.41 99.38 92.04 93.04 66.04 76.63 Inventory Days 53.39 58.90 100.00 145.29 140.07 99.81 78.34 66.02 62.77 94.81 Payable days 136.76 126.93 121.62 102.03 144.40 66.65 73.69 81.82 79.78 95.04 Cash Conversion Cycle 13.80 22.77 82.56 139.87 97.08 132.54 96.69 77.23 49.02 76.39 Total Debt/Equity 0.04 0.06 0.03 0.09 0.06 0.08 0.11 0.06 0.13 0.08 Interest Cover 114.57 108.26 90.62 12.72 35.71 29.31 46.07 61.38 37.23 11.11

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 424.97 326.99 267.06 233.44 224.88 206.04 189.49 165.22 93.63 73.91 ROA 24.35% 22.13% 13.29% 3.43% 9.43% 10.30% 16.02% 23.05% 23.43% 9.72% ROE 27.98% 25.88% 15.66% 4.06% 11.27% 12.71% 19.75% 29.70% 33.21% 14.62% ROCE 32.85% 30.08% 18.06% 4.86% 13.99% 14.82% 23.71% 35.28% 39.21% 18.04% Fixed Asset Turnover 1.25 1.24 0.89 0.76 0.86 1.07 1.47 1.72 1.93 1.23 Receivable days 93.30 86.16 93.53 85.10 84.44 93.77 91.36 92.22 65.12 70.27 Inventory Days 56.17 60.81 95.32 128.47 118.77 96.38 77.28 65.25 62.41 89.35 Payable days 145.20 136.43 133.18 106.38 151.52 65.96 72.53 81.42 78.30 85.42 Cash Conversion Cycle 4.27 10.54 55.67 107.20 51.68 124.19 96.11 76.05 49.23 74.21 Total Debt/Equity 0.04 0.06 0.03 0.09 0.06 0.08 0.11 0.06 0.14 0.09 Interest Cover 96.87 88.16 60.44 12.42 44.58 27.45 43.73 58.61 34.75 10.11

Top Investors:

belgrave investment fund

life insurance corporation of india

tata mutual fund- tata equity p/e fund

akash bhansali

investor education and protection fund (iepf)

Annual Reports:

News Update:

NATCO Pharma launches Bosentan tablets for oral suspension
20th Aug 2025, 11:28 AM

The company holds the first-to-file status for this product and will have 180-day generic drug exclusivity
Read More
Natco Pharma - Quarterly Results
12th Aug 2025, 13:42 PM

Read More
USFDA issues EIR to Natco Pharma’s Hyderabad API division
25th Jul 2025, 16:30 PM

USFDA had conducted an inspection at said facility from June 9, 2025 to June 13, 2025
Read More
Natco Pharma gets nod to incorporate wholly owned subsidiary in South Africa
24th Jul 2025, 11:00 AM

The objective of incorporation of subsidiary is to enter new geographies for growth and increased profitability.
Read More
USFDA concludes inspection at Natco Pharma’s Kothur pharma division
20th Jun 2025, 10:20 AM

On conclusion of the inspection, the Company received seven observations in the Form-483
Read More
USFDA concludes inspection at Natco Pharma’s Hyderabad API manufacturing plant
13th Jun 2025, 16:44 PM

On conclusion of the inspection, the Company received 1 observation in the Form 483
Read More

Natco Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524816 | NSE: NATCOPHARM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Natco Pharma Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524816 | NSE: NATCOPHARM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: